ResearchMoz

Global Display Driver IC Market 2011-2015

Technavio
Published Date » 2012-06-01
No. Of Pages » 34
   
   
TechNavio's analysts forecast the Global Display Driver market to decline at a CAGR of 8.22 percent in terms of revenue over the period 2011-2015. One of the key factors for this decline is the growing popularity of LED display panels. The Global Display Driver market has also been witnessing an increase in portable display devices. However, the high inventories of flat panel displays are acting as a barrier to the market growth.  TechNavio's report, the Global Display Driver Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Display Driver market landscape and its growth prospects in the coming years. The report also includes...
Table of Content

1. Executive Summary

2. Introduction

3. Market Coverage

4. Market Landscape

5. Vendor Landscape

6. Buying Criteria

7. Market Growth Drivers

8. Drivers and their Impact

9. Market Challenges

10. Impact of Drivers and Challenges

11. Market Trends

12. Key Vendor Analysis
12.1 Novatek Microelectronics Corp.
12.2 Samsung Electronics Co. Ltd.
12.3 Renesas Electronics Corp.
12.4 Himax Technologies Inc.
12.5 Magnachip Semiconductor Corp.

13. Other Reports in this Series

List of Tables


Exhibit 1: Global Display Driver IC Market 2011-2015 (US$ billion)
Exhibit 2: Global Display Driver IC Market by Unit Shipment 2011-2015 (in billion)
Exhibit 3: Global LED Display Driver IC Market 2011-2015 (US$ billion)
Exhibit 4: Global Display Driver IC Market by Vendor Segmentation 2011

List of Figures

NA

Upcoming Reports:

Endocrine, Nutritional, & Metabolic Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Endocrine, Nutritional, & Metabolic Disorders include diseases that affect endocrine glands (thyroid, parathyroid, pituitary, adrenals, thymus, islets of pancreas, ovaries and testicles), nutritional deficiencies such as malnutrition and vitamin deficiencies, and metabolism disorders such related  lipid metabolism, carbohydrate metabolism, amino acid metabolism, plasma protein metabolism and other metabolic disorders. Endocrine glands release specific hormones in the blood stream which help in coordinating and controlling several physiological processes in the body. An...
Coal Handling Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Coal handling is the initial process of power generation in every coal fired power plant. From its unloading at the plant site to its subsequent firing in the boiler furnace, the coal goes through a number of preparation and storage phases. These systems are an integral part of the overall coal quality management system and material flow of the power plant. Due to the large number of procedures and equipment’s involved in the coal handling phase, the overall number of possible players in the market is substantial. There are a large number of market drivers propelling both old and...
Alpha-2 Antiplasmin Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Alpha-2 antiplasmin or plasmin inhibitor, is a type of glycoprotein synthesized by the liver, kidneys and other tissues of the body. It is a serine protease inhibitor which belongs to the Serpin superfamily that acts as the primary inhibitor of the serine protease plasmin. Fibrinolysis occurs due to the conversion of plasminogen to serine protease plasmin by plasminogen activator. Deficiency of Alpha 2 antiplasmin causes a bleeding disorder owing to the increase fibrinolysis. Alpha-2 antiplasmin is the protein responsible for the degradation of fibrin clots and inhibition of fibrinolysis....

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Loss recorded due to heavy investments carried out by Amazon
Jul 25, 2014  
Amazon.com Inc has been investing in newer businesses like consumer electronics and digital content, due to which it has been running into losses for some time now. The loss recorded in the second quarter was by far the highest. In 2014, the stock prices have dropped by 10% with reduced investor confidence in the long term growth investments. The shares of this US based online retailer...
LG Electronics To Invest Huge Capital in R&D Project in South Korea
Jul 25, 2014  
LG Electronics Inc will invest USD 1.26 billion in the construction of a new research and development unit in South Korea’s capital city Seoul. The facility is said to be part of LG’s Science Park project. The 170,000 square meters site will be built in Magok, Seoul and work is expected to begin from August. Once the construction is complete and ready by 2020, the park will house...
Russian Consumer Protection Agency Seeks ban on Some McDonalds Products
Jul 25, 2014  
A lawsuit has been filed in a Moscow court by the Russian consumer protection agency to seek ban on some products from McDonald's Corp's burgers menu, along with its ice creams and shakes menu.  A regional branch of the agency has recently filed a lawsuit asking the court to declare a ban on some products due to some inappropriateness in physical-chemical parameters in the...
High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...